Saray Rodríguez-Diaz

CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome

Paula Rodríguez-Márquez, María Eréndira Calleja-Cervantes, Guillermo Serrano et al. · Science Advances · 2022 · 107 citations · Full text

T-regulatory Cell, Immunology, Antitumoral Efficacy +16

CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I

Nerea Zabaleta, Miren Barberia, Cristina Martín-Higueras et al. · Nature Communications · 2018 · 82 citations · Full text

Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia

Cristina Calviño, Candela Ceballos, Ana Alfonso Piérola et al. · Frontiers in Immunology · 2023 · 21 citations · Full text

In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria

Rebeca Martínez-Turrillas, Ángel Martín-Mallo, Saray Rodríguez-Diaz et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 20 citations · Full text

Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation

Natalia Zapata‐Linares, Saray Rodríguez-Diaz, Eduardo Salido et al. · Stem Cell Research · 2015 · 18 citations · Full text

Genetics, Human Polymorphism, Pathology +20